Cargando…

1222. Impact of Microbiology Reporting Changes in Treatment of AmpC Bloodstream Infections

BACKGROUND: Recent literature suggests that AmpC production may be overcalled in Enterobacterales, leading to unnecessary broad-spectrum antimicrobial utilization. The Infectious Diseases Society of America (IDSA) has since reassessed classification of high and low risk organisms with inducible AmpC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wesolowski, Alec, Miller, Jessica, Argotsinger, Jill, Gavaghan, Victoria, Dela-Pena, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679310/ http://dx.doi.org/10.1093/ofid/ofad500.1062

Ejemplares similares

594. A Multi-Centered Study of the Clinical and Molecular Epidemiology of AmpC Cephalosporinase-Producing (AmpC) Enterobacteriaceae (Ent) Infections in Children
por: Medernach, Rachel L, et al.
Publicado: (2019)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
por: Ávila-Núñez, M., et al.
Publicado: (2023)

Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome
por: Pospišil, Mladen, et al.
Publicado: (2023)

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways
por: Skoglund, Erik, et al.
Publicado: (2018)

Ceftolozane-Tazobactam Resistance in Multidrug-Resistant Pseudomonas aeruginosa Isolates Not Associated with AmpC Activity
por: Tran, Truc T, et al.
Publicado: (2017)

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”
por: Skoglund, Erik, et al.
Publicado: (2019)

2775. Clinical Outcomes and Treatment-Emergent Resistance of Piperacillin-tazobactam, Cefepime, Carbapenems and Fluoroquinolones for the Treatment of Bloodstream Infections due to AmpC β-Lactamase-Producing Enterobacterales
por: Jawanda, Jasanjeet, et al.
Publicado: (2023)

254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
por: Staicu, Mary L, et al.
Publicado: (2020)

Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region
por: Chaubey, Vikas P, et al.
Publicado: (2014)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
por: Gunter, Sarah Grace, et al.
Publicado: (2020)

Clinical and microbiological observational study on AmpC β-lactamase-producing Enterobacteriaceae in a hospital of Nepal
por: Baral, Pankaj, et al.
Publicado: (2013)

Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia
por: da Cunha Ferreira, Tiago, et al.
Publicado: (2021)

Database for the ampC alleles in Acinetobacter baumannii
por: Karah, Nabil, et al.
Publicado: (2017)

657. Evaluating Clinical Outcomes of Bacteremic Patients Treated with AmpC-Inducing Versus -Stable Agents
por: Barsoum, Barbara, et al.
Publicado: (2022)

93. Leveraging Stewardship to Promote Narrower-spectrum Antibiotic Use for Low-risk AmpC Enterobacterales
por: Hardy, Megan E, et al.
Publicado: (2023)

663. Improved Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections Using Combined Genotypic and Phenotypic Antimicrobial Susceptibility Testing
por: Khalil, Nadim, et al.
Publicado: (2020)

2431. Evaluation of Clinical Outcomes in Bacteremia Due to AmpC β-Lactamase Producing Organisms Stratified by Treatment
por: Carlson, Travis, et al.
Publicado: (2018)

Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections
por: Gavaghan, Victoria, et al.
Publicado: (2022)

1222. Risk Factors and Outcomes for Daptomycin Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Hadid, Hind, et al.
Publicado: (2018)

2776. Decrease in ceftriaxone treatment failure rates for infections caused by inducible AmpC producing Enterobacterales associated with changes in laboratory susceptibility testing reporting
por: Khan, Ayesha, et al.
Publicado: (2023)

Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC
por: Rodríguez-Guerrero, Enrique, et al.
Publicado: (2022)

Controversies about extended-spectrum and AmpC beta-lactamases.
por: Thomson, K S
Publicado: (2001)

Detection of AmpC β Lactamases in Gram-negative Bacteria
por: Gupta, Gunjan, et al.
Publicado: (2014)

Challenges in detection of AmpC β-lactamases among Enterobacteriaceae
por: Joseph, Noyal Mariya, et al.
Publicado: (2013)

Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?
por: Pérez-Gallego, Marcelo, et al.
Publicado: (2016)

Detection of AmpC β-lactamases in gram-negative bacteria
por: Zhou, Qian, et al.
Publicado: (2022)

Aromatic Diboronic Acids as Effective KPC/AmpC Inhibitors
por: Krajewska, Joanna, et al.
Publicado: (2023)

2399. β-Lactam Therapy for Potential AmpC-Producing Organisms: A Cohort Study and an Updated Systematic Review and Meta-Analysis
por: Cheng, Matthew P, et al.
Publicado: (2018)

2783. Evaluation of Appropriate Antibiotic Prescribing Following Modification of Culture & Susceptibility Cascade for High Risk AmpC-Producing Gram-Negative Bacteria
por: Lim, Andy, et al.
Publicado: (2023)

1014. Microbiology and Outcome of Bloodstream Infections in Children With Intestinal Failure
por: Seddik, Talal, et al.
Publicado: (2018)

Extended-spectrum beta-lactamases screening agar with AmpC inhibition
por: Al Naiemi, N., et al.
Publicado: (2009)

CTX-M and Plasmid-mediated AmpC-Producing Enterobacteriaceae, Singapore
por: Koh, Tse Hsien, et al.
Publicado: (2004)

Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli
por: LIU, XIANGQUN, et al.
Publicado: (2016)

Distribution of ESBL/AmpC-Escherichia coli on a Dairy Farm
por: Homeier-Bachmann, Timo, et al.
Publicado: (2022)

Antibiotic Resistance and Virulence Traits in Vancomycin-Resistant Enterococci (VRE) and Extended-Spectrum β-Lactamase/AmpC-producing (ESBL/AmpC) Enterobacteriaceae from Humans and Pets
por: Iseppi, Ramona, et al.
Publicado: (2020)

Role of AmpR in the High Expression of the Plasmid-Encoded AmpC β-Lactamase CFE-1
por: Nakano, Ryuichi, et al.
Publicado: (2017)

Study on the Role of ampG in the Regulation of Plasmid-Mediated ampC -Induced Expression in Klebsiella pneumoniae
por: Li, Guiling, et al.
Publicado: (2023)

873. Comparison of Antibiotic and Antiviral Use before and after Deployment of Rapid Influenza Testing in the Emergency Department
por: Wesolowski, Alec, et al.
Publicado: (2022)

1281. An Evaluation of Tebipenem In Vitro Activity Against a Panel of Pseudomonas aeruginosa Isolates with Efflux, AmpC, and OprD Mutations
por: VanScoy, Brian D, et al.
Publicado: (2021)

AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India
por: Gupta, Varsha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0io6k27h3k4is58r5kmtbuar5a